BUSINESS● LOW1h ago · Oct 19, 2026, 11:25 AM
Disc Medicine surges on late-stage trial win for lead asset developed with Roche
Seeking Alpha Tech · global
Disc Medicine saw a surge following a successful late-stage trial for a key asset developed in collaboration with Roche. This positive development impacts the company's market performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoMullen Group to acquire customs broker Willson InternationalSeeking Alpha TechBUSINESS43m agoSL Green Realty announces $2B refinancing of 245 Park Avenue propertySeeking Alpha Tech